Ruxolitinib: a new first-line strategy in autoimmune myelofibrosis treatment.

Domenico Penna,Alessia Tieghi,Riccardo Valli,Francesco Merli

Leukemia & lymphoma（2023）

引用 0|浏览7

暂无评分

摘要

Click to increase image sizeClick to decrease image size Disclosure statementNo potential conflict of interest was reported by the authors.Additional informationFundingThis study was partially supported by Italian Ministry of Health – Ricerca Corrente Annual Program 2024.

查看译文

关键词

autoimmune,first-line

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要